Feng Chi Biotech Corp. (TPEX:6744)

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Wholesale - Medical Equipment	177.36M	171.10M	180.58M	193.46M	182.57M
Wholesale - Medical Equipment Growth	3.66%	-5.25%	-6.66%	5.96%	2.05%
Total	177.36M	171.10M	180.58M	193.46M	182.57M
Total Growth	3.66%	-5.25%	-6.66%	5.96%	2.05%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Taiwan	177.36M	171.10M	180.30M	192.89M	178.69M
Taiwan Growth	3.66%	-5.11%	-6.53%	7.95%	5.79%
Other	-	-	274.00K	567.00K	3.88M
Other Growth	-	-	-51.68%	-85.39%	-61.15%
Total	177.36M	171.10M	180.58M	193.46M	182.57M
Total Growth	3.66%	-5.25%	-6.66%	5.96%	2.05%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 12, 2026

Data Sources Report a data error